{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase I\/II Study of Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Patients With Newly Diagnosed Transplant Eligible Multiple Myeloma","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-i-ii-study-of-carfilzomib-iberdomide-cc-220-and-dexamethasone-kid-in-patients-with-newly-diagnosed-transplant-eligible-multiple-myeloma\/#breadcrumbitem"}]}